BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9141917)

  • 21. Calcium binding to extracellular sites of skeletal muscle calcium channels regulates dihydropyridine binding.
    Ebata H; Mills JS; Nemcek K; Johnson JD
    J Biol Chem; 1990 Jan; 265(1):177-82. PubMed ID: 2152918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of daunorubicin on dihydropyridine-sensitive binding sites in cardiac sarcolemma.
    Banning J; Baginski T; Rao V; Abram A
    Biochem Pharmacol; 1987 Dec; 36(24):4362-6. PubMed ID: 2446634
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
    Rasmussen RP; Minobe W; Bristow MR
    Biochem Pharmacol; 1990 Feb; 39(4):691-6. PubMed ID: 2154992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Increased [3H] PN 200-110 binding sites in the myocardial sarcolemmal membrane in endotoxin shock rats].
    Motoyama Y
    Masui; 1994 Jan; 43(1):7-12. PubMed ID: 8309058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dihydropyridine and peripheral type benzodiazepine binding sites: subcellular distribution and molecular size determination.
    Doble A; Benavides J; Ferris O; Bertrand P; Menager J; Vaucher N; Burgevin MC; Uzan A; Gueremy C; Le Fur G
    Eur J Pharmacol; 1985 Dec; 119(3):153-67. PubMed ID: 2419140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pressure overload on cardiac Ca2+ antagonist binding sites of guinea pig. Comparison with the adaptational response of the hypertrophied rat heart.
    Primot I; Mayoux E; Oliviero P; Charlemagne D
    Cardiovasc Res; 1991 Oct; 25(10):875-80. PubMed ID: 1660790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dihydropyridine binding sites in aerobically perfused, ischemic, and reperfused rat hearts: effect of temperature and time.
    Gu XH; Dillon JS; Nayler WG
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):272-8. PubMed ID: 2464098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium channel agonist and antagonist binding in a highly enriched sarcolemma preparation obtained from canine ventricle.
    Rampe D; Poder T; Zhao ZY; Schilling WP
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):547-56. PubMed ID: 2470991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of halothane on sarcolemmal calcium channels during myocardial ischemia and reperfusion.
    Drenger B; Ginosar Y; Gozal Y
    Adv Pharmacol; 1994; 31():89-97. PubMed ID: 7873445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of nifedipine on ischemia-induced changes in the biochemical properties of isolated sarcolemmal vesicles and the ultrastructure of myocardium.
    Lamers JM; Essed CE; Pourquie ME; Hugenholtz PG; Verdouw PD
    Can J Cardiol; 1987; 3(1):39-50. PubMed ID: 3030520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dihydropyridine and beta adrenergic receptor binding in dogs with tachycardia-induced atrial fibrillation.
    Gaspo R; Sun H; Fareh S; Levi M; Yue L; Allen BG; Hebert TE; Nattel S
    Cardiovasc Res; 1999 May; 42(2):434-42. PubMed ID: 10533579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration of voltage-dependent calcium channels in canine brain during global ischemia and reperfusion.
    Hoehner PJ; Blanck TJ; Roy R; Rosenthal RE; Fiskum G
    J Cereb Blood Flow Metab; 1992 May; 12(3):418-24. PubMed ID: 1314842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thermodynamic and kinetic aspects of agonist and antagonist binding to 1,4-dihydropyridine receptors.
    Zheng W; Hawthorn M; Triggle DJ
    Eur J Pharmacol; 1991 Oct; 208(2):137-47. PubMed ID: 1724760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of halothane on voltage-dependent calcium channels in isolated Langendorff-perfused rat heart.
    Lee DL; Zhang J; Blanck TJ
    Anesthesiology; 1994 Nov; 81(5):1212-9. PubMed ID: 7978480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart.
    Harrison GJ; Willis RJ; Headrick JP
    Cardiovasc Res; 1998 Oct; 40(1):74-87. PubMed ID: 9876319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of inorganic calcium channel blockers on dihydropyridine binding to cardiac sarcolemma.
    Schilling WP; Zaher MC; Rampe D
    Mol Pharmacol; 1990 Jan; 37(1):80-9. PubMed ID: 2137194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of [3H]isradipine binding to L-type calcium channels by the optical isomers of isoflurane. Lack of stereospecificity.
    Moody EJ; Harris B; Hoehner P; Skolnick P
    Anesthesiology; 1994 Jul; 81(1):124-8. PubMed ID: 8042780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that cytosolic and ecto 5'-nucleotidases contribute equally to increased interstitial adenosine concentration during porcine myocardial ischemia.
    Lasley RD; Hegge JO; Noble MA; Mentzer RM
    Basic Res Cardiol; 1999 Jun; 94(3):199-207. PubMed ID: 10424238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depression of calcium channel blocker binding to rat brain membranes by halothane.
    Drenger B; Heitmiller ES; Quigg M; Blanck TJ
    Anesth Analg; 1992 May; 74(5):758-61. PubMed ID: 1314528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: lipid bilayer partitioning could occur before drug binding to receptors.
    Herbette LG; Vant Erve YM; Rhodes DG
    J Mol Cell Cardiol; 1989 Feb; 21(2):187-201. PubMed ID: 2545886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.